doi: 10.1055/s-2007-1002624.
Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer
Affiliations
- PMID: 1796300
- DOI: 10.1055/s-2007-1002624
Item in Clipboard
Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer
Semin Thromb Hemost.
1991 Jul.
No abstract available
Similar articles
-
Prognostic impact of urokinase-type plasminogen activator (PA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: a prospective study on multicenter basis.Clin Cancer Res. 1998 Jan;4(1):177-82. Clin Cancer Res. 1998. PMID: 9516968
-
[Prognostic value of urokinase-type plasminogen activator and 2 inhibitors PAI-1 and PAI-2 in breast cancer].Bull Cancer. 1994 Sep;81(9):770-9. Bull Cancer. 1994. PMID: 7703566 French.
-
[Detection of tumor markers in uterine cancer (plasminogen activators, plasminogen activator inhibitors) using fibrin autography].Nihon Sanka Fujinka Gakkai Zasshi. 1992 Oct;44(10):1277-8. Nihon Sanka Fujinka Gakkai Zasshi. 1992. PMID: 1431441 Japanese. No abstract available.
-
Fibrinolysis components as prognostic markers in breast cancer and colorectal carcinoma.Anticancer Res. 1996 Jul-Aug;16(4B):2155-9. Anticancer Res. 1996. PMID: 8694536 Review.
-
[Contribution of biology to the therapeutic decision: cancer of the breast in 1995].Bull Cancer Radiother. 1995;82(2):225-37. Bull Cancer Radiother. 1995. PMID: 7546893 Review. French. No abstract available.
Cited by
-
The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomas.Am J Pathol. 2003 Nov;163(5):1887-99. doi: 10.1016/S0002-9440(10)63547-X. Am J Pathol. 2003. PMID: 14578188 Free PMC article.
-
The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers.Am J Pathol. 1994 Oct;145(4):782-91. Am J Pathol. 1994. PMID: 7943170 Free PMC article.
-
Integration of risk factors to allow patient selection for adjuvant systemic therapy in lymph node-negative breast cancer patients.World J Surg. 1994 Jan-Feb;18(1):39-44. doi: 10.1007/BF00348190. World J Surg. 1994. PMID: 8197775 Review.
-
An ultra-sensitive immunoassay for quantifying biomarkers in breast tumor tissue.J Cancer. 2014 Jan 5;5(2):115-24. doi: 10.7150/jca.8084. eCollection 2014. J Cancer. 2014. PMID: 24494029 Free PMC article.
-
Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.Br J Cancer. 1998 Mar;77(6):932-40. doi: 10.1038/bjc.1998.154. Br J Cancer. 1998. PMID: 9528837 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
